Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 10

Results: 17

Endothelial TRPV4–eNOS coupling as a vital therapy target for treatment of hypertension.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2297, doi. 10.1111/bph.15755

By:

Mao, Aiqin;
Zhang, Peng;
Zhang, Ka;
Kan, Hao;
He, Dongxu;
Han, Xiping;
Wang, Zhiwei;
Tang, Chunlei;
Ma, Xin

Publication type:

Article

CORRECTION.

Published in:: British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2313, doi. 10.1111/bph.15829
Publication type:: Article

Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic‐ and cholestatic‐induced liver injury.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2275, doi. 10.1111/bph.15752

By:

Benitez, Raquel;
Caro, Marta;
Andres‐Leon, Eduardo;
O'Valle, Francisco;
Delgado, Mario

Publication type:

Article

Alzheimer's disease and cerebrovascular pathology alter inward rectifier potassium (KIR2.1) channels in endothelium of mouse cerebral arteries.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2259, doi. 10.1111/bph.15751

By:

Lacalle‐Aurioles, María;
Trigiani, Lianne J.;
Bourourou, Miled;
Lecrux, Clotilde;
Hamel, Edith

Publication type:

Article

Nicotinic‐acid derivative BGP‐15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2240, doi. 10.1111/bph.15749

By:

Priksz, Daniel;
Lampe, Nora;
Kovacs, Arpad;
Herwig, Melissa;
Bombicz, Mariann;
Varga, Balazs;
Wilisicz, Tician;
Szilvassy, Judit;
Posa, Aniko;
Kiss, Rita;
Gesztelyi, Rudolf;
Raduly, Arnold;
Szekeres, Reka;
Sieme, Marcel;
Papp, Zoltan;
Toth, Attila;
Hamdani, Nazha;
Szilvassy, Zoltan;
Juhasz, Bela

Publication type:

Article

Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; β‐arrestins and GPCR kinases.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2223, doi. 10.1111/bph.15748

By:

Patel, Monica;
Matti, Christoph;
Grimsey, Natasha L.;
Legler, Daniel F.;
Javitch, Jonathan A.;
Finlay, David B.;
Glass, Michelle

Publication type:

Article

Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2086, doi. 10.1111/bph.15587

By:

Subramaniam, Saravanan;
Ruf, Wolfram;
Bosmann, Markus

Publication type:

Article

Glucosylsphingosine evokes pruritus via activation of 5‐HT2A receptor and TRPV4 in sensory neurons.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2193, doi. 10.1111/bph.15733

By:

Sanjel, Babina;
Kim, Bo‐Hyun;
Song, Myung‐Hyun;
Carstens, Earl;
Shim, Won‐Sik

Publication type:

Article

Treatment with senicapoc, a KCa3.1 channel blocker, alleviates hypoxaemia in a mouse model of acute respiratory distress syndrome.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2175, doi. 10.1111/bph.15704

By:

Petersen, Asbjørn Graver;
Lind, Peter Carøe;
Mogensen, Susie;
Jensen, Anne‐Sophie Bonde;
Granfeldt, Asger;
Simonsen, Ulf

Publication type:

Article

Pyroptosis targeting via mitochondria: An educated guess to innovate COVID‐19 therapies.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2081, doi. 10.1111/bph.15670

By:

Singh, Aarti;
Strobbe, Daniela;
Campanella, Michelangelo

Publication type:

Article

Thromboinflammation in coronavirus disease 2019: The clot thickens.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2100, doi. 10.1111/bph.15594

By:

Iffah, Raayma;
Gavins, Felicity N. E.

Publication type:

Article

Proteinase‐activated receptor‐2 antagonist C391 inhibits Alternaria‐induced airway epithelial signalling and asthma indicators in acute exposure mouse models.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2208, doi. 10.1111/bph.15745

By:

Rivas, Candy M.;
Yee, Michael C.;
Addison, Kenneth J.;
Lovett, Marissa;
Pal, Kasturi;
Ledford, Julie G.;
Dussor, Gregory;
Price, Theodore J.;
Vagner, Josef;
DeFea, Kathryn A.;
Boitano, Scott

Publication type:

Article

The impact of COVID‐19 on pregnancy and therapeutic drug development.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2108, doi. 10.1111/bph.15582

By:

Abbas‐Hanif, Allyah;
Rezai, Homira;
Ahmed, Syed Faraz;
Ahmed, Asif

Publication type:

Article

Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID‐19.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2121, doi. 10.1111/bph.15461

By:

Cinar, Resat;
Iyer, Malliga R.;
Kunos, George

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2079, doi. 10.1111/bph.15553
Publication type:: Article

Therapeutic strategies to fight COVID‐19: Which is the status artis?

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2128, doi. 10.1111/bph.15452

By:

Scavone, Cristina;
Mascolo, Annamaria;
Rafaniello, Concetta;
Sportiello, Liberata;
Trama, Ugo;
Zoccoli, Alice;
Bernardi, Francesca Futura;
Racagni, Giorgio;
Berrino, Liberato;
Castaldo, Giuseppe;
Coscioni, Enrico;
Rossi, Francesco;
Capuano, Annalisa

Publication type:

Article

Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 10, p. 2149, doi. 10.1111/bph.15397

By:

Pignataro, Giuseppe;
Cataldi, Mauro;
Taglialatela, Maurizio

Publication type:

Article

Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 10

Endothelial TRPV4–eNOS coupling as a vital therapy target for treatment of hypertension.

CORRECTION.

Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic‐ and cholestatic‐induced liver injury.

Alzheimer's disease and cerebrovascular pathology alter inward rectifier potassium (K<sub>IR</sub>2.1) channels in endothelium of mouse cerebral arteries.

Nicotinic‐acid derivative BGP‐15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.

Delineating the interactions between the cannabinoid CB<sub>2</sub> receptor and its regulatory effectors; β‐arrestins and GPCR kinases.

Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019.

Glucosylsphingosine evokes pruritus via activation of 5‐HT<sub>2A</sub> receptor and TRPV4 in sensory neurons.

Treatment with senicapoc, a K<sub>Ca</sub>3.1 channel blocker, alleviates hypoxaemia in a mouse model of acute respiratory distress syndrome.

Pyroptosis targeting via mitochondria: An educated guess to innovate COVID‐19 therapies.

Thromboinflammation in coronavirus disease 2019: The clot thickens.

Proteinase‐activated receptor‐2 antagonist C391 inhibits Alternaria‐induced airway epithelial signalling and asthma indicators in acute exposure mouse models.

The impact of COVID‐19 on pregnancy and therapeutic drug development.

Dual inhibition of CB<sub>1</sub> receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID‐19.

Issue Information.

Therapeutic strategies to fight COVID‐19: Which is the status artis?

Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence.